EUVIMEDEUVIMED entdecken
Crossref

LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer

Mei-Ling Tian iD, Bin Li, Yan Li iD, Hong-Wei Fan, Nai-Yi Du, Shan Kang

Journal of Obstetrics and Gynaecology Research · 2024-12 · 50 (12) · 2271-2279

DOI: 10.1111/jog.16077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 10.10.2024. Verfasst von Mei-Ling Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Ovarian Epithelial, Drug Resistance, Neoplasm, Ovarian Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, Precision Medicine Joint Fund Cultivation Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The purpose of this experiment is to explore the role of long intergenic noncoding RNA 261 (LINC00261) gene in the chemoresistance and clinical prognosis of epithelial ovarian cancer (EOC).

Methods

We used matrix‐assisted laser desorption ionization time‐of‐flight (MALDI‐TOF) mass spectrometry to detect the methylation levels of the LINC00261 promoter region in EOC patient specimens. The expression levels of LINC00261, miR‐545‐3p, and MT1M in EOC patients were evaluated by quantitative real‐time reverse transcriptase PCR (RT‐qPCR). Spearman's correlation analysis was used for relevance analyses and clinical prognosis was counted by Kaplan–Meier analysis. Stable overexpressed LINC00261 SKOV3 cells were established to test the influence of LINC00261 on proliferation, platinum sensitivity, migration, and invasion.

Results

The promoter region methylation level of the LINC00261 was hypermethylated and LINC00261 was significantly downregulated in platinum‐resistant EOC tissues. The methylation level of LINC00261was significantly negative correlated with its RNA expression in EOC. Moreover, hypermethylation and lower expression of LINC00261 in EOC patients were related to shorter progression‐free survival (PFS) and overall survival (OS). Furthermore, Spearman's correlation analysis showed that the expression of miR‐545‐3p had a negative relevance with LINC00261. According to the website prediction, MT1M might be the downstream target gene of LINC00261. Expression of MT1M was negatively correlated with miR‐545‐3p and positively with LINC00261 in EOC tissues. And lower MT1M mRNA expression was correlated with chemotherapy resistance and worse prognosis. In vitro, overexpression of LINC00261 could inhibit cisplatin resistance, proliferation, and suppression of migration and invasion in SKOV3 cells.

Conclusions

This research indicates that the aberrant hypermethylation and low expression of LINC00261 were associated with platinum resistance and adverse outcomes in EOC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, Ovarian EpithelialDrug Resistance, NeoplasmOvarian NeoplasmsHumansFemalePrognosisMiddle AgedDNA MethylationCell Line, TumorAdultGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

LINC00261epithelial ovarian cancerhypermethylationplatinum resistanceprognosis

Substanzen

RNA, Long Noncodinglong non-coding RNA 00261, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China.
  • Department of Obstetrics and Gynecology, Hebei General Hospital, Shijiazhuang, China.
  • Department of Gynecology, Handan Central Hospital, Handan, Hebei, China.
  • Department of Molecular Biology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Mei-Ling Tian, Yan Li

Förderung

  • Natural Science Foundation of Hebei Province
  • Precision Medicine Joint Fund Cultivation Project of Hebei

Zitieren

APA

Tian, M. L., Li, B., Li, Y., Fan, H. W., Du, N. Y., & Kang, S. (2024). LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer. Journal of Obstetrics and Gynaecology Research, 50(12), 2271-2279. https://doi.org/10.1111/jog.16077

Vancouver

Tian ML, Li B, Li Y, Fan HW, Du NY, Kang S. LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer. Journal of Obstetrics and Gynaecology Research. 2024;50(12):2271-2279. doi:10.1111/jog.16077

BibTeX
@article{Tian2024,
  author = {Tian, Mei-Ling and Li, Bin and Li, Yan and Fan, Hong-Wei and Du, Nai-Yi and Kang, Shan},
  title = {LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2024},
  volume = {50},
  number = {12},
  pages = {2271--2279},
  doi = {10.1111/jog.16077}
}
Kostenlos starten →